litlas
ログインアカウント作成

Barry A. Borlaug

2005–2026 年に発表

別表記
Barry A Borlaug
348
論文数
52,075
被引用数
119
h 指数
312
i10 指数

被引用数

Barry A. Borlaug の年別被引用数1979 年: 被引用 1 件1996 年: 被引用 51 件2001 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 2 件2006 年: 被引用 15 件2007 年: 被引用 34 件2008 年: 被引用 58 件2009 年: 被引用 73 件2010 年: 被引用 111 件2011 年: 被引用 121 件2012 年: 被引用 166 件2013 年: 被引用 258 件2014 年: 被引用 355 件2015 年: 被引用 338 件2016 年: 被引用 422 件2017 年: 被引用 421 件2018 年: 被引用 462 件2019 年: 被引用 1,350 件2020 年: 被引用 1,797 件2021 年: 被引用 1,990 件2022 年: 被引用 1,923 件2023 年: 被引用 1,697 件2024 年: 被引用 3,691 件2025 年: 被引用 2,902 件2026 年: 被引用 94 件1980〜1995 年は被引用が無いため表示していません1997〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,775 件、この内訳の 24.2%イギリス: 引用元論文 1,045 件、この内訳の 6.7%イタリア: 引用元論文 984 件、この内訳の 6.3%ドイツ: 引用元論文 915 件、この内訳の 5.9%中国: 引用元論文 862 件、この内訳の 5.6%カナダ: 引用元論文 688 件、この内訳の 4.4%オランダ: 引用元論文 674 件、この内訳の 4.3%オーストラリア: 引用元論文 483 件、この内訳の 3.1%フランス: 引用元論文 478 件、この内訳の 3.1%日本: 引用元論文 456 件、この内訳の 2.9%スペイン: 引用元論文 392 件、この内訳の 2.5%ベルギー: 引用元論文 376 件、この内訳の 2.4%
0%24.2%その他 28.6%

機関

分野

  • Medicine88.3%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Engineering1.8%
  • Immunology and Microbiology0.9%
  • Health Professions0.7%
  • Neuroscience0.7%
  • その他1.1%

トピック

  • Cardiovascular Function and Risk Factors16.6%
  • Heart Failure Treatment and Management9.8%
  • Pulmonary Hypertension Research and Treatments5%
  • Diabetes Treatment and Management3.9%
  • Cardiac Imaging and Diagnostics2.7%
  • Cardiovascular and exercise physiology2.5%
  • その他59.5%

共著者

全論文

検索で開く
  1. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

    著者: Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug, Javed Butler, Søren Rasmussen, Melanie J. Davies, G. Kees Hovingh, Dalane W. Kitzman, Marie L.S. Lindegaard, Daniél V. Møller, Sanjiv J. Shah, Marianne Bach Treppendahl, Subodh Verma, Walter P. Abhayaratna, Fozia Ahmed, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Merkely, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Kavita Sharma, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Mark C. Petrie - New England Journal of Medicine 2023 被引用: 1,436

  2. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

    著者: Mikhail Kosiborod, Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, G. Kees Hovingh, Dalane W. Kitzman, Daniél V. Møller, Marianne Bach Treppendahl, Subodh Verma, Thomas Jensen, Karoline Liisberg, Marie L.S. Lindegaard, Walter P. Abhayaratna, Fozia Ahmed, Tuvia Ben‐Gal, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Merkely, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Kavita Sharma, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Sanjiv J. Shah - New England Journal of Medicine 2024 被引用: 632

  3. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

    著者: Milton Packer, Michael R. Zile, Christopher M. Kramer, Seth J. Baum, Sheldon E. Litwin, Venu Menon, Junbo Ge, Govinda Weerakkody, Ou Yang, Mathijs C. Bunck, Karla Hurt, Masahiro Murakami, Barry A. Borlaug - New England Journal of Medicine 2024 被引用: 783

  4. Heart Failure With Preserved Ejection Fraction

    著者: Barry A. Borlaug, Kavita Sharma, Sanjiv J. Shah, Jennifer E. Ho - Journal of the American College of Cardiology 2023 被引用: 608

  5. Heart Failure With Preserved Ejection Fraction

    著者: Margaret M. Redfield, Barry A. Borlaug - JAMA 2023 被引用: 597

  6. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction

    著者: Masaru Obokata, Yogesh N.V. Reddy, Sorin V. Pislaru, Vojtěch Melenovský, Barry A. Borlaug - Circulation 2017 被引用: 1,117

  7. A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction

    著者: Yogesh N.V. Reddy, Rickey E. Carter, Masaru Obokata, Margaret M. Redfield, Barry A. Borlaug - Circulation 2018 被引用: 1,230

  8. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets

    著者: Barry A. Borlaug, Michael D. Jensen, Dalane W. Kitzman, Carolyn S.P. Lam, Masaru Obokata, Oliver J. Rider - Cardiovascular Research 2022 被引用: 413

  9. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

    著者: Javed Butler, Sanjiv J. Shah, Mark C. Petrie, Barry A. Borlaug, Steen Z. Abildstrøm, Melanie J. Davies, G. Kees Hovingh, Dalane W. Kitzman, Daniél Vega Møller, Subodh Verma, Mette Nygaard Einfeldt, Marie L.S. Lindegaard, Søren Rasmussen, Walter P. Abhayaratna, Fozia Ahmed, Tuvia Ben‐Gal, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Merkely, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Kavita Sharma, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Mikhail Kosiborod - The Lancet 2024 被引用: 323

  10. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

    著者: Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug, Dalane W. Kitzman, Sanjiv J. Shah, Fengming Tang, Yevgeniy Khariton, Ali O. Malik, Taiyeb Khumri, Guillermo E. Umpierrez, Sumant Lamba, Kavita Sharma, Sadiya S. Khan, Lokesh Chandra, Robert Gordon, John Ryan, Sunit‐Preet Chaudhry, Susan Joseph, C. Chow, Manreet Kanwar, Michael Pursley, Elias S. Siraj, Gregory D. Lewis, Barry S. Clemson, Michael Fong, Mikhail Kosiborod - Nature Medicine 2021 被引用: 604

  11. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

    著者: Barry A. Borlaug, Dalane W. Kitzman, Melanie J. Davies, Søren Rasmussen, Eric Barros, Javed Butler, Mette Nygaard Einfeldt, G. Kees Hovingh, Daniél Vega Møller, Mark C. Petrie, Sanjiv J. Shah, Subodh Verma, Walter P. Abhayaratna, Fozia Ahmed, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Mikhail Kosiborod - Nature Medicine 2023 被引用: 188

  12. Evaluation and management of heart failure with preserved ejection fraction

    著者: Barry A. Borlaug - Nature Reviews Cardiology 2020 被引用: 660

  13. Heart Failure With Preserved Ejection Fraction In Perspective

    著者: Marc A. Pfeffer, Amil M. Shah, Barry A. Borlaug - Circulation Research 2019 被引用: 830

  14. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

    著者: Mikhail Kosiborod, John Deanfield, Richard Pratley, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Scott S. Emerson, Steven E. Kahn, Dalane W. Kitzman, Ildiko Lingvay, Kenneth W. Mahaffey, Mark C. Petrie, Jorge Plutzky, Søren Rasmussen, Cecilia Rönnbäck, Sanjiv J. Shah, Subodh Verma, Peter Weeke, A. Michael Lincoff - The Lancet 2024 被引用: 264

  15. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation

    著者: Yogesh N.V. Reddy, Masaru Obokata, Frederik H. Verbrugge, Grace Lin, Barry A. Borlaug - Journal of the American College of Cardiology 2020 被引用: 388

  16. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction

    著者: Sanjiv J. Shah, Dalane W. Kitzman, Barry A. Borlaug, Loek van Heerebeek, Michael R. Zile, David A. Kass, Walter J. Paulus - Circulation 2016 被引用: 980

  17. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction

    著者: Katlyn E. Koepp, Masaru Obokata, Yogesh N.V. Reddy, Thomas P. Olson, Barry A. Borlaug - JACC Heart Failure 2020 被引用: 257

  18. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging

    著者: Arnold C.T. Ng, Victoria Delgado, Barry A. Borlaug, Jeroen J. Bax - Nature Reviews Cardiology 2020 被引用: 321

  19. Research Priorities for Heart Failure With Preserved Ejection Fraction

    著者: Sanjiv J. Shah, Barry A. Borlaug, Dalane W. Kitzman, Andrew D. McCulloch, Burns C. Blaxall, Rajiv Agarwal, Julio A. Chirinos, Sheila Collins, Rahul C. Deo, Mark T. Gladwin, Henk Granzier, Scott L. Hummel, David A. Kass, Margaret M. Redfield, Flora Sam, Thomas J. Wang, Patrice Desvigne‐Nickens, Bishow B. Adhikari - Circulation 2020 被引用: 417

  20. Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction

    著者: Masaru Obokata, Garvan C. Kane, Yogesh N.V. Reddy, Thomas P. Olson, Vojtěch Melenovský, Barry A. Borlaug - Circulation 2016 被引用: 552

  21. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction

    著者: Barry A. Borlaug, Rick A. Nishimura, Paul Sorajja, Carolyn S.P. Lam, Margaret M. Redfield - Circulation Heart Failure 2010 被引用: 1,105

  22. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality

    著者: Frederik H. Verbrugge, Kazunori Omote, Yogesh N.V. Reddy, Hidemi Sorimachi, Masaru Obokata, Barry A. Borlaug - European Heart Journal 2021 被引用: 194

  23. The pathophysiology of heart failure with preserved ejection fraction

    著者: Barry A. Borlaug - Nature Reviews Cardiology 2014 被引用: 696

  24. Exercise Intolerance in Patients With Heart Failure

    著者: Marco Giuseppe Del Buono, Ross Arena, Barry A. Borlaug, Salvatore Carbone, Justin M. Canada, Danielle L. Kirkman, Ryan S. Garten, Paula Rodriguez‐Miguelez, Marco Guazzi, Carl J. Lavie, Antonio Abbate - Journal of the American College of Cardiology 2019 被引用: 445